Home | Screening data | Screen comparisons | Search for compounds | Structure search

Compound InformationSONAR Target prediction
Name:

HETACILLIN POTASSIUM

Unique Identifier:SPE01500327
MolClass: Checkout models in ver1.5 and ver1.0
Molecular Formula:
Molecular Weight:405.385 g/mol
X log p:8.707  (online calculus)
Lipinksi Failures1
TPSA106.05
Hydrogen Bond Donor Count:0
Hydrogen Bond Acceptors Count:7
Rotatable Bond Count:3
Canonical Smiles:[K+].[O-]C(=O)C1N2C(SC1(C)C)C(N1C(=O)C(NC1(C)C)c1ccccc1)C2=O
Source:semisynthetic
Therapeutics:antibacterial
Generic_name:Hetacillin
Chemical_iupac_name:7-(2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl)-3,3-dimethyl-6-oxo-2-thia-5-azabic
yclo[3.2.0]heptane-4-carboxylic acid
Drug_type:Approved Drug
Kegg_compound_id:C11729
Drugbank_id:APRD01012
Melting_point:190 oC
Logp:1.856
Cas_registry_number:3511-16-8
Drug_category:Anti-bacterial Agents; Penicillins; ATC:J01CA18
Pharmacology:Hetacillin is a penicillin beta-lactam antibiotic used in the treatment of bacterial
infections caused by susceptible, usually gram-positive, organisms. The name
"penicillin" can either refer to several variants of penicillin available, or to the
group of antibiotics derived from the penicillins. Hetacillin has in vitro activity
against gram-positive and gram-negative aerobic and anaerobic bacteria. The
bactericidal activity of Hetacillin results from the inhibition of cell wall
synthesis and is mediated through Hetacillin binding to penicillin binding proteins
(PBPs).
Mechanism_of_action:Hetacillin is a semisynthetic penicillin prodrug which itself has no antibacterial
activity, but is converted in the body to ampicillin and has actions and uses
similar to those of ampicillin. Hetacillin is prepared by reacting ampicillin with
acetone. Ampicillin rapidly decomposes because of the intramolecular attack of the
side chain amino group on the lactam ring. Hetacillin locks up the offending amino
group and prevents the decompolsition Hetacillin, once hydrolyzed to ampicillin (and
acetone) binds to the penicillin binding proteins found in susceptible bacteria.
This inhibits the third and last stage of bacterial cell wall synthesis. Cell lysis
is then mediated by bacterial cell wall autolytic enzymes such as autolysins
Organisms_affected:Enteric bacteria and other eubacteria

Found: 205 nonactive as graph: single | with analogs 2 3 4 5 6 7 8 9 10  Next >> [205]
Species: 4932
Condition: BCK1
Replicates: 2
Raw OD Value: r im 0.8845±0.0353553
Normalized OD Score: sc h 0.9956±0.00546572
Z-Score: 0.3770±0.113476
p-Value: 0.707108
Z-Factor: -2.24219
Fitness Defect: 0.3466
Bioactivity Statement: Nonactive
Experimental Conditions
Library:Spectrum_ED
Plate Number and Position:3|B11
Drug Concentration:50.00 nM
OD Absorbance:595 nm
Robot Temperature:30.00 Celcius
Date:2010-08-10 YYYY-MM-DD
Plate CH Control (+):0.09575±0.00727
Plate DMSO Control (-):0.9517500000000001±0.01995
Plate Z-Factor:0.9054
png
ps
pdf

DBLink | Rows returned: 102 Next >> 
3595 6-(2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2
-carboxylate
3596 6-(2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2
-carboxylic acid
19967 potassium
6-(2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2
-carboxylate
68632 potassium
(2S,5R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.
2.0]heptane-2-carboxylate
68633 (2S,5R)-6-[(4R)-2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl]-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.
2.0]heptane-2-carboxylic acid
108240 sodium
6-(2,2-dimethyl-5-oxo-4-phenyl-imidazolidin-1-yl)-3,3-dimethyl-7-oxo-4-thia-1-azabicyclo[3.2.0]heptane-2
-carboxylate

internal high similarity DBLink | Rows returned: 2
SPE01503101 0.9251
SPE01500489 0.9402

active | Cluster 13186 | Additional Members: 1 | Rows returned: 0

Service provided by the Mike Tyers Laboratory